D. Replace potassium first and defer insulin until serum potassium exceeds 3.5 mmol/L
Why this is correct
Insulin deficiency and hyperosmolality redistribute potassium from cells to plasma in DKA even though urinary losses commonly create substantial total-body potassium depletion. A serum potassium of 3.1 mmol/L therefore signals marked deficiency. Insulin drives potassium intracellularly and may provoke dangerous arrhythmia or respiratory weakness if started before correction. The 2024 international adult hyperglycemic-crisis consensus recommends replacing potassium and delaying insulin when serum potassium is below 3.5 mmol/L, while continuing close clinical, cardiac and laboratory monitoring.
Why each option is correct or incorrect
Bicarbonate is not routinely indicated for DKA and potassium-free bicarbonate does not solve severe potassium depletion.
Immediate insulin at K 3.1 mmol/L can worsen hypokalemia and precipitate dangerous arrhythmia.
Total-body potassium is generally depleted in DKA; low measured serum potassium is especially concerning.
Correct: correct severe hypokalemia before insulin per contemporary DKA consensus recommendations.
High-yield notes
- DKA can have total-body potassium depletion even with initially normal or elevated serum K.
- Insulin shifts potassium intracellularly and can worsen hypokalemia.
- 2024 adult consensus: defer insulin if K is below 3.5 mmol/L and replace potassium first.
Low potassium is a safety-critical exception to immediate insulin in DKA.
Older teaching often cites 3.3 mmol/L; the 2024 adult consensus uses a 3.5 mmol/L threshold.